Cerebral venous thrombosis accounts for 0.5% to 3% of all strokes. The most vulnerable
populations include young individuals, women of reproductive age, and patients with a …

Extracorporeal membrane oxygenation (ECMO) was first started for humans in early 1970s
by Robert Bartlett. Since its inception, there have been numerous challenges with …

Background Fusobacterium necrophorum is an anaerobic, gram-negative, non-motile,
filamentous, non-spore forming bacillus found in the oral cavity, gastrointestinal tract, and …

Background Venous thromboembolism (VTE) is rare in patients aged< 21 years. Young
adults aged 18 to 21 years are frequently included in adult VTE studies, whereas pediatric …

Studies from the past 50 years have contributed to the expanding knowledge regarding
developmental hemostasis. This is a dynamic process that begins in the fetal phase and is …

Background Central venous catheters (CVCs) represent one of the main risk factors for
venous thrombotic events (VTEs) in children. Methods We studied the Italian Registry of …

In response to growing recognition that nonadherence prevents children, adolescents, and
young adults from achieving the therapeutic benefits of anticoagulant medication, the …

Iron deficiency anemia has a high prevalence in children and has repeatedly been
implicated as a risk factor for arterial and venous thrombosis. As an effective therapy for iron …

Despite the growing number of pediatric antithrombotic clinical trials, standardized safety
and efficacy outcome definitions for pediatric venous thromboembolism (VTE) clinical trials …

Critically ill children with SARS-CoV-2-related illnesses are at increased risk of thrombosis.
Thromboprophylaxis should be considered in select patients with COVID-19 or MIS-C …